Ruling out preeclampsia in the next 4 weeks using a soluble fms-like tyrosine kinase 1/placental growth factor ratio ≤38: secondary analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia

Eitemau Tebyg

• The ratio of soluble fms–like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia- a secondary analysis of the INSPIRE trial
  gan: Palma Dos Reis, CR, et al.
  Cyhoeddwyd: (2024)
• Randomized interventional study on prediction of preeclampsia/eclampsia in women with suspected preeclampsia
  gan: Cerdeira, A, et al.
  Cyhoeddwyd: (2019)
• Performance of sFlt-1/PlGF ratio ≥85 for ruling in preeclampsia within 4 weeks
  gan: Cerdeira, AS, et al.
  Cyhoeddwyd: (2020)
• The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
  gan: Kifle, MM, et al.
  Cyhoeddwyd: (2022)
• Soluble fms-like tyrosine kinase-1-to-placental growth factor ratio and time to delivery in women with suspected preeclampsia
  gan: Zeisler, H, et al.
  Cyhoeddwyd: (2016)